🏥HHS Agency Information Collection Request for Public Comment Overview
In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment.
Learn More💉CDC Announces Meeting on Vaccine Recommendations and Public Comments
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment.
Learn More📋Indian Affairs Public Health Needs Assessment Information Collection Notice
In accordance with the Paperwork Reduction Act of 1995, the Assistant Secretary--Indian Affairs (AS-IA) is proposing to renew an information collection.
Learn More🏥Amended Meeting Notice from the National Heart, Lung, and Blood Institute
The notice provides updates on the rescheduling of the National Heart, Lung, and Blood Advisory Council meeting. It specifies the new start and end times and indicates that the meeting will partially be closed to the public, while referencing a prior publication in the Federal Register.
Learn More📄CDC Advisory Committee Charter Renewal Announcement
The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the renewal of the charter of the Advisory Committee to the Director (ACD).
Learn More🚫FDA Issues 5-Year Debarment Order Against Evan Asher Field
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Evan Asher Field for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Field was convicted of one felony count under Federal law. The factual basis supporting Mr. Field's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Field was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of April 25, 2024 (30 days after receipt of the notice), Mr. Field had not responded. Mr. Field's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.
Learn More💉National Vaccine Injury Compensation Program Petitions Received
HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.
Learn More💻NIH Office of AIDS Research Advisory Council Meeting Notice
The Department of Health and Human Services announces a virtual meeting of the Office of AIDS Research Advisory Council to discuss key reports and strategic plans related to HIV research. The meeting will be accessible to the public, allowing stakeholders to participate and provide input on the agenda items.
Learn More💊FDA Revokes Emergency Use Authorizations for Specific Drug Products
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorizations (EUAs) (the Authorizations) issued to Fresenius Medical Care North America (Fresenius) for multiFiltrate PRO System and multiBic/multiPlus solutions (EUA 048), and to Baxter Healthcare Corp. (Baxter) for REGIOCIT (EUA 068). FDA revoked the Authorizations on January 16, 2025, under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocations, including an explanation of the reasons for the revocations, are reprinted in this document.
Learn More🏥HRSA's Proposed Information Collection for HIV/AIDS Program Activities
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
Learn More